Deutsch
Deutschland
Anmelden
Tipp von eurobuch.de
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Buch verkaufen
Anbieter, die das Buch mit der ISBN 9783034807081 ankaufen:
Suchtools
Buchtipps
Aktuelles
Werbung
Bezahlte Anzeige
FILTER
- 0 Ergebnisse
Kleinster Preis: 1,31 €, größter Preis: 181,89 €, Mittelwert: 93,17 €
Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - Alexandre Trifilieff
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Alexandre Trifilieff:
Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - gebunden oder broschiert

2013, ISBN: 3034807082

Hardcover, [EAN: 9783034807081], Springer, Springer, Book, [PU: Springer], 2013-11-27, Springer, Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are available. This book provides a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled ss2 agonist for the treatment of COPD. It reviews the current pharmacotherapy for COPD and discusses topics such as the chemical design and the pre-clinical pharmacology of the molecule, the early clinical development, the INHANCE study (which provides a successful example of the use of an adaptive design in the confirmatory setting) and the Phase III clinical efficacy study, as well as the history and performance of the Breezhaler device. Finally, a list of emerging targets is included that could well offer future treatment options for COPD., 270890, Respiratory, 270842, Internal Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 270945, Pharmacology, 270906, Other Branches of Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 922532, Medicine, 270792, Basic Science, 922534, Dentistry, 922610, Diseases & Disorders, 922810, Education, 922556, Hospital Administration & Management, 922558, Medical Ethics & Legal Issues, 922560, Medical Research & Equipment, 922572, Medical Sciences A-Z, 270781, Midwifery, 922778, Nursing, 922802, Optometry, 922804, Pharmacy, 922806, Physiotherapy, 922808, Reference, 57, Science & Nature, 1025612, Subjects, 266239, Books, 571382, Medical Sciences A-Z, 571384, Anaesthetics, 571400, Cardiovascular, 571334, Diseases & Disorders, 571390, Gynaecology & Obstetrics, 571386, Neurology, 571316, Orthopaedic & Fractures, 571388, Paediatrics, 571362, Pathology, 571392, Psychiatry, 571290, Public Health & Preventive Medicine, 571350, Radiology & Medical Imaging, 571280, Research & Equipment, 571310, Surgery, 564356, Medicine & Nursing, 564334, Scientific, Technical & Medical, 1025612, Subjects, 266239, Books

gebrauchtes bzw. antiquarisches Buch Amazon.co.uk
hufelandhaus
Gebraucht. Versandkosten:Europa Zone 1: GBP 5,48 pro Produkt.. Usually dispatched within 1-2 business days. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 4.80)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - Alexandre Trifilieff
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Alexandre Trifilieff:
Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - gebunden oder broschiert

2013, ISBN: 3034807082

Hardcover, [EAN: 9783034807081], Springer, Springer, Book, [PU: Springer], 2013-11-27, Springer, Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are available. This book provides a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled ss2 agonist for the treatment of COPD. It reviews the current pharmacotherapy for COPD and discusses topics such as the chemical design and the pre-clinical pharmacology of the molecule, the early clinical development, the INHANCE study (which provides a successful example of the use of an adaptive design in the confirmatory setting) and the Phase III clinical efficacy study, as well as the history and performance of the Breezhaler device. Finally, a list of emerging targets is included that could well offer future treatment options for COPD., 270890, Respiratory, 270842, Internal Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 270945, Pharmacology, 270906, Other Branches of Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 922532, Medicine, 270792, Basic Science, 922534, Dentistry, 922610, Diseases & Disorders, 922810, Education, 922556, Hospital Administration & Management, 922558, Medical Ethics & Legal Issues, 922560, Medical Research & Equipment, 922572, Medical Sciences A-Z, 270781, Midwifery, 922778, Nursing, 922802, Optometry, 922804, Pharmacy, 922806, Physiotherapy, 922808, Reference, 57, Science & Nature, 1025612, Subjects, 266239, Books, 571382, Medical Sciences A-Z, 571384, Anaesthetics, 571400, Cardiovascular, 571334, Diseases & Disorders, 571390, Gynaecology & Obstetrics, 571386, Neurology, 571316, Orthopaedic & Fractures, 571388, Paediatrics, 571362, Pathology, 571392, Psychiatry, 571290, Public Health & Preventive Medicine, 571350, Radiology & Medical Imaging, 571280, Research & Equipment, 571310, Surgery, 564356, Medicine & Nursing, 564334, Scientific, Technical & Medical, 1025612, Subjects, 266239, Books

Neues Buch Amazon.co.uk
SuperBookDealsUK
Neuware. Versandkosten:Europa Zone 1: GBP 5,48 pro Produkt.. Usually dispatched within 1-2 business days. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 4.80)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Indacaterol. - Trifilieff, Alexandre (Ed.)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Trifilieff, Alexandre (Ed.):
Indacaterol. - gebunden oder broschiert

2014, ISBN: 3034807082

ID: 21071744613

[EAN: 9783034807081], [SC: 3.0], [PU: Basel, Birkhäuser Verlag, 2014.], ANÄSTHESIE/PHARMAKOLOGIE, The First Once-daily Long-acting Beta2 Agonist for COPD. Milestones in Drug Therapy. VII, 146 p. 235 mm x 155 mm. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped.

gebrauchtes bzw. antiquarisches Buch ZVAB.com
Antiquariat im Hufelandhaus GmbH, Berlin, Germany [2726420] [Rating: 5 (von 5)]
Versandkosten: EUR 3.00
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Indacaterol: the First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - Trifilieff, Alexandre
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Trifilieff, Alexandre:
Indacaterol: the First Once-Daily Long-Acting Beta2 Agonist for Copd (Milestones in Drug Therapy) - gebunden oder broschiert

2013, ISBN: 9783034807081

ID: 12916206340

Hardcover, Gebraucht, guter Zustand, Spine creases, wear to binding and pages from reading. May contain limited notes, underlining or highlighting that does affect the text. Possible ex library copy, that'll have the markings and stickers associated from the library. Accessories such as CD, codes, toys, may not be included. , [PU: Springer]

gebrauchtes bzw. antiquarisches Buch Alibris.com
Owls Books
Versandkosten:zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Indacaterol The First Once-daily Long-acting Beta2 Agonist for COPD - Trifilieff, Alexandre (Herausgeber)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Trifilieff, Alexandre (Herausgeber):
Indacaterol The First Once-daily Long-acting Beta2 Agonist for COPD - gebunden oder broschiert

2013, ISBN: 3034807082

ID: A21937680

2014 Gebundene Ausgabe Pharmakologie, Asthma; Beta-2-Agonists; Bronchitis; Bronchodilatator; Lung function, mit Schutzumschlag neu, [PU:Springer Basel; Springer Basel AG]

Neues Buch Achtung-Buecher.de
MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
Versandkosten:Versandkostenfrei innerhalb der BRD. (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

Details zum Buch
Indacaterol The First Once-Daily Long-Acting Beta2 Agonist for COPD

Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are available. This book provides a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled ss2 agonist for the treatment of COPD. It reviews the current pharmacotherapy for COPD and discusses topics such as the chemical design and the pre-clinical pharmacology of the molecule, the early clinical development, the INHANCE study (which provides a successful example of the use of an adaptive design in the confirmatory setting) and the Phase III clinical efficacy study, as well as the history and performance of the Breezhaler device. Finally, a list of emerging targets is included that could well offer future treatment options for COPD.

Detailangaben zum Buch - Indacaterol The First Once-Daily Long-Acting Beta2 Agonist for COPD


EAN (ISBN-13): 9783034807081
ISBN (ISBN-10): 3034807082
Gebundene Ausgabe
Erscheinungsjahr: 2014
Herausgeber: Springer

Buch in der Datenbank seit 14.09.2014 18:56:16
Buch zuletzt gefunden am 19.04.2018 14:33:34
ISBN/EAN: 9783034807081

ISBN - alternative Schreibweisen:
3-0348-0708-2, 978-3-0348-0708-1


< zum Archiv...
Benachbarte Bücher